Cytotoxic T-lymphocyte associated protein 4, also known as CD152, is a protein receptor that functions as an immune checkpoint and downregulates immune responses. From Wikipedia
Backed by more than £1 million in memorial fundraising, the Win-Glio study will recruit 16 glioblastoma patients over 18 months to receive ipilimumab before conventional therapy.
